| Term 
 | Definition 
 
        | 
Network of enzymes mostly in the liver (some are located in the GI tract) 
 
Metabolizes endogenous (ie hormones, steroid, lipids, etc) & exogenous substances (ie medications) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | ÷Subgroups responsible for the metabolism of many drugs ¢3A4 ¢2D6 ¢2C9, 10, 19 ¢1A2 ¢2E1 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | utilizes the CYP450 system for metabolism |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   ¡Tricyclic Antidepressants (TCAs) ¡Warfarin (Coumadin®) ¡Theophylline  ÷Chemically similar to caffeine ¡Caffeine  |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   ¡Non-Steroidal Anti-inflammatories (NSAIDs) ¡Oral hypoglycemics  ¡Warfarin (Coumadin®)  |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   ¡Proton Pump Inhibitors (PPIs) ÷Used for GERD ¡Antiepileptic drugs  |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Beta Blockers Antipsychotics Antidepressants ÷TCAs ÷Selective Serotonin Reuptake Inhibitors (SSRIs) 
 Codeine ÷Problem for patients with genetic enzyme problem ÷Must be transformed before it is active; therefore, patient cannot feel relief from codeine |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   ¡Anesthetics ¡Acetaminophen (Tylenol®) ¡Ethanol |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   ¡Antibiotics-Macrolides  ¡Benzodiazepines (BZDs) ÷Used for anxiety ¡Immunosuppressants  ÷Patients could become very ill, if other 3A is being used, therefore, immunosuppressants gro up ÷If given medication that induces 3A, then body will reject organ ¡HIV antivirals  ¡Calcium Channel Blockers (CCBs) ¡Statins  ¡Hormones (estrogen, progesterone) Many other miscellaneous |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   Some medications have the capacity to increase the activity of CYP 450 enzymes ÷More activity of CYP 450 enzymesàIncreased metabolism àLower plasma concentration |  | 
        |  | 
        
        | Term 
 
        |   Consequences of CPY 450 induction |  | Definition 
 
        |   ÷Decreased plasma drug concentrations ÷If inactive metabolite: decreased drug activity (¯therapeutic effects) ÷If the drug has an active metabolite, induction may increase the activity of the medication (but in general it is assumed that induction will decrease the activity) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1A2: foods (broccoli, brussel sprouts, other), tobacco smoke 2C9: Rifampin  2C19: Rifampin, Carbamazepine  2D6: Rifampin  2E1: Ethanol 3A (4,5,7): HIV antivirals, Barbiturates (phenobarbital), Carbamazepine, Phenytoin (Dilantin®), Rifampin  
 Overall Common CYP 450 Inducers ¡Phenobarbital, Phenytoin, Rifampin, Carbamazepine (Tegretol®) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   Some medications have the capacity to decrease the activity of CYP450 enzymes ÷Less activity of CYP 450àdecreased metabolism àhigher concentration of plasma drug levelsàpossible side effects or toxicity |  | 
        |  | 
        
        | Term 
 
        | Common CYP 450 Inhibitors |  | Definition 
 
        | ¡1A2: Fluroquinolones (FQs) ¡2C9: Azole Antifungals  ¡2C19: PPIs, Some Antidepressants (SSRIs, TCAs) ¡3A (4,5,7): HIV antivirals, macrolide antibiotics, azole antifungals, grapefruit juice, CCBs 
 Overall common inhibitors  ¡Cimetadine (Tagamet®), Grapefruit juice, Amiodarone  |  | 
        |  |